Human papillomavirus 16 or 18 infection and prostate cancer risk: A meta-analysis

Irish Journal of Medical Science

Volumn 180, Issue 2, 2011, Pages 497-503

  Lin, Y ^a   Mao, Q ^a   Zheng, X ^a   Yang, K ^a   Chen, H ^a   Zhou, C ^a   Xie, L ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Etiology; Human papillomavirus; Meta analysis; Prostate cancer

Indexed keywords

VIRUS DNA;

ARTICLE; CANCER RISK; CASE STUDY; COMPARATIVE STUDY; DISEASE ASSOCIATION; DNA DETERMINATION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 16 INFECTION; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 18 INFECTION; META ANALYSIS; PAPILLOMAVIRUS INFECTION; PREVALENCE; PROSTATE CANCER; QUANTITATIVE ANALYSIS; SYSTEMATIC ERROR; SYSTEMATIC REVIEW; THEORETICAL MODEL; VIRUS DETECTION;

HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; MALE; ODDS RATIO; PAPILLOMAVIRUS INFECTIONS; PROSTATIC NEOPLASMS; RISK FACTORS;

EID: 79955572337     PISSN: 00211265     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11845-011-0692-6     Document Type: Article

References (54)

1. Jemal A, Siegel R, Ward E et al (2009) Cancer statistics. CA Cancer J Clin 59(4):225-249
2. Shavers VL, Underwood W, Moser RP (2009) Race/ethnicity and the perception of the risk of developing prostate cancer. Am J Prev Med 37(1):64-67
3. Strickler HD, Goedert JJ (2001) Sexual behavior and evidence for an infectious cause of prostate cancer. Epidemiol Rev 23(1):144-151 (Pubitemid 32906627)
4. Hoffman LJ, Bunker CH, Pellett PE et al (2004) Elevated sero-prevalence of human herpesvirus 8 among men with prostate cancer. J Infect Dis 189(1):15-20 (Pubitemid 38122324)
5. Taylor ML, Mainous AG 3rd, Wells BJ (2005) Prostate cancer and sexually transmitted diseases: a meta-analysis. Fam Med 37(7):506-512 (Pubitemid 40967713)
6. Tjalma WA, Van Waes TR, Van den Eeden LE, Bogers JJ (2005) Role of human papillomavirus in the carcinogenesis of squamous cell carcinoma and adenocarcinoma of the cervix. Best Pract Res Clin Obstet Gynaecol 19(4):469-483 (Pubitemid 41263800)
7. Daling JR, Madeleine MM, Johnson LG et al (2004) Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer. Cancer 101(2):270-280 (Pubitemid 38890829)
8. Dennis LK, Dawson DV (2002) Meta-analysis of measures of sexual activity and prostate cancer. Epidemiology 13(1):72-79 (Pubitemid 34031513)
9. Dennis LK, Lynch CF, Torner JC (2002) Epidemiologic association between prostatitis and prostate cancer. Urology 60(1):78-83 (Pubitemid 34722951)
10. Naghashfar Z, DiPaolo JA, Woodworth CD, Passaniti A (1996) Immortalization of human adult prostatic adenocarcinoma cells by human papilloma virus HPV16 and -18 DNA. Cancer Lett 100(1-2):47-54
11. Choo CK, Ling MT, Chan KW et al (1999) Immortalization of human prostate epithelial cells by HPV 16 E6/E7 open reading frames. Prostate 40(3):150-158
12. Moyret-Lalle C, Marcais C, Jacquemier J et al (1995) ras, p53 and HPV status in benign and malignant prostate tumors. Int J Cancer 64(2):124-129
13. Dillner J, Knekt P, Boman J et al (1998) Sero-epidemiological association between human-papillomavirus infection and risk of prostate cancer. Int J Cancer 75(4):564-567 (Pubitemid 28094102)
14. Serth J, Panitz F, Paeslack U, Kuczyk MA, Jonas U (1999) Increased levels of human papillomavirus type 16 DNA in a subset of prostate cancers. Cancer Res 59(4):823-825 (Pubitemid 29086734)
15. Carozzi F, Lombardi FC, Zendron P et al (2004) Association of human papillomavirus with prostate cancer: analysis of a consecutive series of prostate biopsies. Int J Biol Markers 19(4):257-261 (Pubitemid 40124845)
16. Korodi Z, Dillner J, Jellum E et al (2005) Human papillomavirus 16, 18, and 33 infections and risk of prostate cancer: a Nordic nested case-control study. Cancer Epidemiol Biomarkers Prev 14(12):2952-2955 (Pubitemid 43068830)
17. Leiros GJ, Galliano SR, Sember ME et al (2005) Detection of human papillomavirus DNA and p53 codon 72 polymorphism in prostate carcinomas of patients from Argentina. BMC Urol 5:15
18. Sutcliffe S, Giovannucci E, Gaydos CA et al (2007) Plasma antibodies against Chlamydia trachomatis, human papillomavirus, and human herpesvirus type 8 in relation to prostate cancer: a prospective study. Cancer Epidemiol Biomarkers Prev 16(8):1573-1580 (Pubitemid 47294821)
19. Huang WY, Hayes R, Pfeiffer R et al (2008) Sexually transmissible infections and prostate cancer risk. Cancer Epidemiol Biomarkers Prev 17(9):2374-2381
20. Sutcliffe S, Viscidi RP, Till C et al (2010) Human papillomavirus types 16, 18, and 31 serostatus and prostate cancer risk in the Prostate Cancer Prevention Trial. Cancer Epidemiol Biomarkers Prev 19(2):614-618
21. Aghakhani A, Hamkar R, Parvin M et al (2011) The role of human papillomavirus infection in prostate carcinoma. Scand J Infect Dis 43:64-69
22. Sitas F, Urban M, Stein L et al (2007) The relationship between anti-HPV-16 IgG seropositivity and cancer of the cervix, anogenital organs, oral cavity and pharynx, oesophagus and prostate in a black South African population. Infect agents cancer 2:6
23. May M, Kalisch R, Hoschke B et al (2008) Detection of papillomavirus DNA in the prostate: a virus with underestimated clinical relevance? Der Urologe Ausg 47(7):846-852
24. Lau J, Ioannidis JP, Schmid CH (1997) Quantitative synthesis in systematic reviews. Ann Intern Med 127(9):820-826 (Pubitemid 27465551)
25. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22(4):719-748
26. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177-188 (Pubitemid 17189972)
27. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629-634 (Pubitemid 27387172)
28. McNicol PJ, Dodd JG (1990) Detection of human papillomavirus DNA in prostate gland tissue by using the polymerase chain reaction amplification assay. J Clin Microbiol 28(3):409-412 (Pubitemid 20078104)
29. Masood S, Rhatigan RM, Powell S, Thompson J, Rodenroth N (1991) Human papillomavirus in prostatic cancer: no evidence found by in situ DNA hybridization. South Med J 84(2):235-236
30. McNicol PJ, Dodd JG (1991) High prevalence of human papillomavirus in prostate tissues. J Urol 145(4):850-853
31. Anwar K, Nakakuki K, Shiraishi T et al (1992) Presence of ras oncogene mutations and human papillomavirus DNA in human prostate carcinomas. Cancer Res 52(21):5991-5996
32. Ibrahim GK, Gravitt PE, Dittrich KL et al (1992) Detection of human papillomavirus in the prostate by polymerase chain reaction and in situ hybridization. J Urol 148(6):1822-1826
33. Rotola A, Monini P, Di Luca D et al (1992) Presence and physical state of HPV DNA in prostate and urinary-tract tissues. Int J Cancer 52(3):359-365
34. Tu H, Jacobs SC, Mergner WJ, Kyprianou N (1994) Rare incidence of human papillomavirus types 16 and 18 in primary and metastatic human prostate cancer. Urology 44(5):726-731
35. Anderson M, Handley J, Hopwood L et al (1997) Analysis of prostate tissue DNA for the presence of human papillomavirus by polymerase chain reaction, cloning, and automated sequencing. J Med Virol 52(1):8-13 (Pubitemid 27243547)
36. Gherdovich S, Barbacci P, Mitrione MP et al (1997) Detection of the human papillomavirus in hyperplastic and cancerous prostatic tissue with PCR. Minerva urologica e nefrologica Italian J Urol Nephrol 49(2):73-77 (Pubitemid 127511179)
37. Terris MK, Peehl DM (1997) Human papillomavirus detection by polymerase chain reaction in benign and malignant prostate tissue is dependent on the primer set utilized. Urology 50(1):150-156 (Pubitemid 27300385)
38. Noda T, Sasagawa T, Dong Y et al (1998) Detection of human papillomavirus (HPV) DNA in archival specimens of benign prostatic hyperplasia and prostatic cancer using a highly sensitive nested PCR method. Urol Res 26(3):165-169 (Pubitemid 28305380)
39. Strickler HD, Burk R, Shah K et al (1998) A multifaceted study of human papillomavirus and prostate carcinoma. Cancer 82(6):1118-1125 (Pubitemid 28136526)
40. Hayes RB, Pottern LM, Strickler H et al (2000) Sexual behaviour, STDs and risks for prostate cancer. Br J Cancer 82(3):718-725 (Pubitemid 30085213)
41. Hisada M, Rabkin CS, Strickler HD et al (2000) Human papillomavirus antibody and risk of prostate cancer. JAMA 283(3):340-341 (Pubitemid 30051749)
42. Adami HO, Kuper H, Andersson SO, Bergstrom R, Dillner J (2003) Prostate cancer risk and serologic evidence of human papilloma virus infection: a population-based case-control study. Cancer Epidemiol Biomarkers Prev 12(9):872-875 (Pubitemid 37151522)
43. Rosenblatt KA, Carter JJ, Iwasaki LM, Galloway DA, Stanford JL (2003) Serologic evidence of human papillomavirus 16 and 18 infections and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 12(8):763-768 (Pubitemid 36993167)
44. Bergh J, Marklund I, Gustavsson C et al (2007) No link between viral findings in the prostate and subsequent cancer development. Br J Cancer 96(1):137-139 (Pubitemid 46094651)
45. Gazzaz FS, Mosli HA (2009) Lack of detection of human papillomavirus infection by hybridization test in prostatic biopsies. Saudi Med J 30(5):633-637
46. Silvestre RV, Leal MF, Demachki S et al (2009) Low frequency of human papillomavirus detection in prostate tissue from individuals from Northern Brazil. Memorias do Instituto Oswaldo Cruz 104(4):665-667
47. Kaplan HS (1961) The role of cell differentiation as a determinant of susceptibility to virus carcinogenesis. Cancer Res 21:981-983
48. Chaturvedi AK (2010) Beyond cervical cancer: burden of other HPV-related cancers among men and women. J Adolesc Health 46(4 Suppl):S20-S26
49. Kong DB, Zheng XY, Xie LP, Sima N (2009) Is prostate cancer an HPV-associated lesion? Med Hypotheses 72(1):101
50. Colon-Lopez V, Ortiz AP, Palefsky J (2010) Burden of human papillomavirus infection and related comorbidities in men: implications for research, disease prevention and health promotion among Hispanic men. Puerto Rico Health Sci J 29(3):232-240
51. Castellsague X, Schneider A, Kaufmann AM, Bosch FX (2009) HPV vaccination against cervical cancer in women above 25 years of age: key considerations and current perspectives. Gynecol Oncol 115(3 Suppl):S15-S23
52. Mammas IN, Vageli D, Spandidos DA (2008) Geographic variations of human papilloma virus infection and their possible impact on the effectiveness of the vaccination programme. Oncol Rep 20(1):141-145
53. Srinivasan M, Taioli E, Ragin CC (2009) Human papillomavirus type 16 and 18 in primary lung cancers - a meta-analysis. Carcinogenesis 30(10):1722-1728
54. Iwasaka T, Hayashi Y, Yokoyama M et al (1992) 'Hit and run' oncogenesis by human papillomavirus type 18 DNA. Acta Obstet Gynecol Scand 71(3):219-223